A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).
Conditions
Eosinophilic Esophagitis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Campbelltown Private Hospital, Sydney, New South Wales, Australia
Contact: Principal Investigator (Vincent Ho, MD)Mater Hospital Brisbane, Brisbane, Queensland, Australia
Contact: Principal Investigator (Yoon-Kyo An)Princess Alexandra Hospital, Brisbane, Queensland, Australia
Contact: Principal Investigator (Gerald Holtmann, MD)Coastal Digestive Health, Maroochydore, Queensland, Australia
Contact: Principal Investigator (Hans Seltenreich)Royal Adelaide Hospital, Adelaide, South Australia, Australia
Contact: Principal Investigator (Nam Nguyen, MD)Eastern Health Box Hill, Box Hill, Victoria, Australia
Contact: Principal Investigator (Sanjay Nandurkar, MD)Northern Hospital Epping, Epping, Victoria, Australia
Contact: Principal Investigator (Mayur Garg)The Alfred Hospital, Melbourne, Victoria, Australia
Contact: Principal Investigator (Rebecca Burgell)Royal Melbourne Hospital, Parkville, Victoria, Australia
Contact: Principal Investigator (Nicholas Hannah)University of Calgary, Calgary, Alberta, Canada
Contact: Principal Investigator (Milli Gupta)UoA - South Edmonton Gastroenterology Research Clinic, Edmonton, Alberta, Canada
Contact: Principal Investigator (Jesse Siffledeen)G.I. Research Institute, Vancouver, British Columbia, Canada
Contact: Principal Investigator (Hin Hin Ko, MD)McGill University Health Center, Montreal, Quebec, Canada
Contact: Principal Investigator (Waqqas Afif, MD)Amsterdam UMC, Amsterdam, Netherlands
Erasmus University Medical Center, Holland, Netherlands
Contact: Principal Investigator (Peter Siersema)Aotearoa Clinical Trials, Papatoetoe, Auckland, New Zealand
Contact: Principal Investigator (Tien Huey Lim)Waikato Hospital, Hamilton, New Zealand
Contact: Principal Investigator (Frank Weilert)Capital Coast and Hutt, Lower Hutt, New Zealand
Contact: Principal Investigator (Stephen Inns)Universitätsspital Zürich, Zurich, Switzerland
Contact: Principal Investigator (Christopher Schlag)Norfolk and Norwich University Hospital, Norwich, Norfolk, United Kingdom
Contact: Principal Investigator (Ian Beales)Cardiff and Vale University Health Board-Wales, Cardiff, United Kingdom
Contact: Principal Investigator (Hasan N Haboubi)Royal Liverpool University Hospital, Liverpool, United Kingdom
Contact: Principal Investigator (Andrew Moore)St George's University of London, London, United Kingdom
Contact: Principal Investigator (Jamal Hayat)
Study leads
Mark Kowalski, MD PhD
Study Director
Eupraxia Pharmaceuticals